nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—PTGS1—Thalidomide—leprosy	0.137	0.152	CbGbCtD
Terbinafine—PTGS1—Dapsone—leprosy	0.11	0.122	CbGbCtD
Terbinafine—CYP2C8—Rifampicin—leprosy	0.0767	0.0851	CbGbCtD
Terbinafine—CYP2C19—Thalidomide—leprosy	0.0664	0.0737	CbGbCtD
Terbinafine—CYP2C19—Rifampicin—leprosy	0.0643	0.0714	CbGbCtD
Terbinafine—CYP2C8—Dapsone—leprosy	0.0633	0.0702	CbGbCtD
Terbinafine—CYP1A2—Thalidomide—leprosy	0.0613	0.068	CbGbCtD
Terbinafine—CYP1A2—Rifampicin—leprosy	0.0593	0.0659	CbGbCtD
Terbinafine—CYP2C9—Thalidomide—leprosy	0.0552	0.0613	CbGbCtD
Terbinafine—CYP2C9—Rifampicin—leprosy	0.0535	0.0593	CbGbCtD
Terbinafine—CYP2C19—Dapsone—leprosy	0.0531	0.0589	CbGbCtD
Terbinafine—CYP2C9—Dapsone—leprosy	0.0441	0.049	CbGbCtD
Terbinafine—CYP3A4—Rifampicin—leprosy	0.0311	0.0345	CbGbCtD
Terbinafine—CYP3A4—Dapsone—leprosy	0.0257	0.0285	CbGbCtD
Terbinafine—Toxic skin eruption—Thalidomide—leprosy	0.00954	0.0962	CcSEcCtD
Terbinafine—Skin exfoliation—Dapsone—leprosy	0.00258	0.026	CcSEcCtD
Terbinafine—Foetor hepaticus—Thalidomide—leprosy	0.00244	0.0246	CcSEcCtD
Terbinafine—Toothache—Thalidomide—leprosy	0.00227	0.023	CcSEcCtD
Terbinafine—Psoriasis—Thalidomide—leprosy	0.0022	0.0222	CcSEcCtD
Terbinafine—Liver disorder—Thalidomide—leprosy	0.00203	0.0205	CcSEcCtD
Terbinafine—Cholestasis—Thalidomide—leprosy	0.00182	0.0184	CcSEcCtD
Terbinafine—Nasopharyngitis—Dapsone—leprosy	0.00175	0.0177	CcSEcCtD
Terbinafine—Influenza—Dapsone—leprosy	0.0017	0.0171	CcSEcCtD
Terbinafine—Pancreatitis—Dapsone—leprosy	0.00166	0.0168	CcSEcCtD
Terbinafine—Blood disorder—Thalidomide—leprosy	0.00166	0.0167	CcSEcCtD
Terbinafine—Jaundice cholestatic—Thalidomide—leprosy	0.00157	0.0159	CcSEcCtD
Terbinafine—Photosensitivity reaction—Dapsone—leprosy	0.00155	0.0156	CcSEcCtD
Terbinafine—Skin discolouration—Thalidomide—leprosy	0.00153	0.0155	CcSEcCtD
Terbinafine—Hearing impaired—Thalidomide—leprosy	0.00145	0.0147	CcSEcCtD
Terbinafine—Hepatocellular injury—Thalidomide—leprosy	0.00138	0.014	CcSEcCtD
Terbinafine—Eructation—Thalidomide—leprosy	0.00136	0.0137	CcSEcCtD
Terbinafine—Skin exfoliation—Thalidomide—leprosy	0.00132	0.0133	CcSEcCtD
Terbinafine—Blood urea increased—Thalidomide—leprosy	0.00131	0.0132	CcSEcCtD
Terbinafine—Tinnitus—Dapsone—leprosy	0.00127	0.0128	CcSEcCtD
Terbinafine—Lightheadedness—Thalidomide—leprosy	0.00124	0.0125	CcSEcCtD
Terbinafine—Erythema—Dapsone—leprosy	0.00118	0.0119	CcSEcCtD
Terbinafine—Photosensitivity—Thalidomide—leprosy	0.00114	0.0115	CcSEcCtD
Terbinafine—Deafness—Thalidomide—leprosy	0.00112	0.0113	CcSEcCtD
Terbinafine—Eczema—Thalidomide—leprosy	0.00112	0.0113	CcSEcCtD
Terbinafine—Vision blurred—Dapsone—leprosy	0.00111	0.0112	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Thalidomide—leprosy	0.00106	0.0107	CcSEcCtD
Terbinafine—Vertigo—Dapsone—leprosy	0.00106	0.0107	CcSEcCtD
Terbinafine—Visual disturbance—Thalidomide—leprosy	0.00106	0.0107	CcSEcCtD
Terbinafine—Dermatitis bullous—Thalidomide—leprosy	0.00105	0.0106	CcSEcCtD
Terbinafine—Arthritis—Thalidomide—leprosy	0.00103	0.0104	CcSEcCtD
Terbinafine—Cough—Dapsone—leprosy	0.00103	0.0104	CcSEcCtD
Terbinafine—Hypoglycaemia—Thalidomide—leprosy	0.00103	0.0104	CcSEcCtD
Terbinafine—Cramp muscle—Thalidomide—leprosy	0.000904	0.00913	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000904	0.00913	CcSEcCtD
Terbinafine—Influenza—Thalidomide—leprosy	0.000868	0.00876	CcSEcCtD
Terbinafine—Eosinophilia—Thalidomide—leprosy	0.00086	0.00867	CcSEcCtD
Terbinafine—Pancreatitis—Thalidomide—leprosy	0.000851	0.00859	CcSEcCtD
Terbinafine—Pancytopenia—Thalidomide—leprosy	0.000824	0.00832	CcSEcCtD
Terbinafine—Neutropenia—Thalidomide—leprosy	0.000812	0.00819	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Thalidomide—leprosy	0.000807	0.00814	CcSEcCtD
Terbinafine—Photosensitivity reaction—Thalidomide—leprosy	0.000792	0.008	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dapsone—leprosy	0.000789	0.00796	CcSEcCtD
Terbinafine—Weight decreased—Thalidomide—leprosy	0.000785	0.00793	CcSEcCtD
Terbinafine—Infestation—Thalidomide—leprosy	0.000774	0.00781	CcSEcCtD
Terbinafine—Infestation NOS—Thalidomide—leprosy	0.000774	0.00781	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000767	0.00774	CcSEcCtD
Terbinafine—Abdominal pain—Dapsone—leprosy	0.000762	0.00769	CcSEcCtD
Terbinafine—Body temperature increased—Dapsone—leprosy	0.000762	0.00769	CcSEcCtD
Terbinafine—Agranulocytosis—Thalidomide—leprosy	0.000722	0.00729	CcSEcCtD
Terbinafine—Hepatitis—Thalidomide—leprosy	0.000695	0.00701	CcSEcCtD
Terbinafine—Hypoaesthesia—Thalidomide—leprosy	0.000691	0.00698	CcSEcCtD
Terbinafine—Visual impairment—Thalidomide—leprosy	0.00067	0.00676	CcSEcCtD
Terbinafine—Erythema multiforme—Thalidomide—leprosy	0.000657	0.00663	CcSEcCtD
Terbinafine—Eye disorder—Thalidomide—leprosy	0.000649	0.00655	CcSEcCtD
Terbinafine—Tinnitus—Thalidomide—leprosy	0.000648	0.00654	CcSEcCtD
Terbinafine—Angiopathy—Thalidomide—leprosy	0.00063	0.00636	CcSEcCtD
Terbinafine—Immune system disorder—Thalidomide—leprosy	0.000628	0.00633	CcSEcCtD
Terbinafine—Alopecia—Thalidomide—leprosy	0.000614	0.0062	CcSEcCtD
Terbinafine—Vomiting—Dapsone—leprosy	0.000613	0.00619	CcSEcCtD
Terbinafine—Mental disorder—Thalidomide—leprosy	0.000609	0.00614	CcSEcCtD
Terbinafine—Headache—Dapsone—leprosy	0.000604	0.0061	CcSEcCtD
Terbinafine—Flatulence—Thalidomide—leprosy	0.000596	0.00602	CcSEcCtD
Terbinafine—Dysgeusia—Thalidomide—leprosy	0.000592	0.00598	CcSEcCtD
Terbinafine—Muscle spasms—Thalidomide—leprosy	0.000582	0.00587	CcSEcCtD
Terbinafine—Nausea—Dapsone—leprosy	0.000573	0.00578	CcSEcCtD
Terbinafine—Vision blurred—Thalidomide—leprosy	0.00057	0.00575	CcSEcCtD
Terbinafine—Ill-defined disorder—Thalidomide—leprosy	0.000561	0.00566	CcSEcCtD
Terbinafine—Anaemia—Thalidomide—leprosy	0.000559	0.00564	CcSEcCtD
Terbinafine—Angioedema—Thalidomide—leprosy	0.000553	0.00558	CcSEcCtD
Terbinafine—Malaise—Thalidomide—leprosy	0.000545	0.0055	CcSEcCtD
Terbinafine—Vertigo—Thalidomide—leprosy	0.000543	0.00548	CcSEcCtD
Terbinafine—Cough—Thalidomide—leprosy	0.000528	0.00533	CcSEcCtD
Terbinafine—Arthralgia—Thalidomide—leprosy	0.000515	0.0052	CcSEcCtD
Terbinafine—Myalgia—Thalidomide—leprosy	0.000515	0.0052	CcSEcCtD
Terbinafine—Chest pain—Thalidomide—leprosy	0.000515	0.0052	CcSEcCtD
Terbinafine—Anxiety—Thalidomide—leprosy	0.000513	0.00518	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000511	0.00516	CcSEcCtD
Terbinafine—Discomfort—Thalidomide—leprosy	0.000509	0.00513	CcSEcCtD
Terbinafine—Dry mouth—Thalidomide—leprosy	0.000504	0.00508	CcSEcCtD
Terbinafine—Confusional state—Thalidomide—leprosy	0.000498	0.00502	CcSEcCtD
Terbinafine—Infection—Thalidomide—leprosy	0.00049	0.00495	CcSEcCtD
Terbinafine—Nervous system disorder—Thalidomide—leprosy	0.000484	0.00489	CcSEcCtD
Terbinafine—Thrombocytopenia—Thalidomide—leprosy	0.000483	0.00488	CcSEcCtD
Terbinafine—Skin disorder—Thalidomide—leprosy	0.00048	0.00484	CcSEcCtD
Terbinafine—Anorexia—Thalidomide—leprosy	0.000471	0.00475	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00045	0.00454	CcSEcCtD
Terbinafine—Paraesthesia—Thalidomide—leprosy	0.000443	0.00447	CcSEcCtD
Terbinafine—Dyspepsia—Thalidomide—leprosy	0.000435	0.00439	CcSEcCtD
Terbinafine—Decreased appetite—Thalidomide—leprosy	0.000429	0.00433	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Thalidomide—leprosy	0.000426	0.0043	CcSEcCtD
Terbinafine—Fatigue—Thalidomide—leprosy	0.000426	0.0043	CcSEcCtD
Terbinafine—Pain—Thalidomide—leprosy	0.000422	0.00426	CcSEcCtD
Terbinafine—Feeling abnormal—Thalidomide—leprosy	0.000407	0.00411	CcSEcCtD
Terbinafine—Gastrointestinal pain—Thalidomide—leprosy	0.000404	0.00407	CcSEcCtD
Terbinafine—Urticaria—Thalidomide—leprosy	0.000392	0.00396	CcSEcCtD
Terbinafine—Body temperature increased—Thalidomide—leprosy	0.00039	0.00394	CcSEcCtD
Terbinafine—Abdominal pain—Thalidomide—leprosy	0.00039	0.00394	CcSEcCtD
Terbinafine—Hypersensitivity—Thalidomide—leprosy	0.000364	0.00367	CcSEcCtD
Terbinafine—Asthenia—Thalidomide—leprosy	0.000354	0.00357	CcSEcCtD
Terbinafine—Pruritus—Thalidomide—leprosy	0.000349	0.00352	CcSEcCtD
Terbinafine—Diarrhoea—Thalidomide—leprosy	0.000338	0.00341	CcSEcCtD
Terbinafine—Dizziness—Thalidomide—leprosy	0.000326	0.00329	CcSEcCtD
Terbinafine—Vomiting—Thalidomide—leprosy	0.000314	0.00317	CcSEcCtD
Terbinafine—Rash—Thalidomide—leprosy	0.000311	0.00314	CcSEcCtD
Terbinafine—Dermatitis—Thalidomide—leprosy	0.000311	0.00314	CcSEcCtD
Terbinafine—Headache—Thalidomide—leprosy	0.000309	0.00312	CcSEcCtD
Terbinafine—Nausea—Thalidomide—leprosy	0.000293	0.00296	CcSEcCtD
